The percentage of infiltrating CD86+/F4/80+ cells in the GPC3-expressing tumor was approximately 15.93% in the region of monocytes and macrophages (Fig. 1D), whereas it was only 5% in the control tumors. The gene discussed is CD86; the disease is neoplasm.